Novalitha Pharma Private Limited

Novalitha Pharma Private Limited - food and beverages in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24303TG2018PTC126911 Incorporated 20 September 2018 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company food and beverages
Revenue · FY 2023
₹84.41 Lakh
▼ 55% YoY
Net loss · FY 2023
₹8.65 Lakh
Net margin -10.2%
EBITDA · FY 2023
-₹5.68 Lakh
EBITDA margin -6.7%
Authorised capital
₹40 Lakh
Registered with MCA
Paid-up capital
₹40 Lakh
Issued & subscribed
Open charges
₹27 Lakh
Secured borrowings
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings

About Novalitha Pharma Private Limited

Data last updated:

Novalitha Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 20 September 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24303TG2018PTC126911.

The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹40 Lakh. It is led by directors Surya Rao Easarla (Managing Director) and Veera Venkata Ramana Easarla.

Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Hyderabad, Telangana.

As per the financials filed for FY 2023, the company reported a revenue of ₹84.41 Lakh, a decline of 55% compared to the previous year. For the same year it recorded a net loss of ₹8.65 Lakh (net margin -10.2%) and EBITDA of -₹5.68 Lakh (EBITDA margin -6.7%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years.

As per MCA filings, the company has open charges of ₹27 Lakh on record. The company has 2 deals on record (1 funding round, 1 rights issue), with disclosed funding of ₹9 Lakh; the latest was in February 2021. Its 10 peer companies in the same principal business activity (retail trading) are compared by revenue, 5 larger and 5 smaller; the largest is Abhiraj Agencies Private Limited with revenue of ₹84.48 Lakh.

Company details

CIN U24303TG2018PTC126911
Registration Number 126911
Incorporation Date 20 September 2018
ROC Hyderabad
Listing Status Unlisted
Company Status Active

Contact details

Novalitha Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.

  • Email
  • Registered Address
    F – 301 7 – 2 – 1735 And 1813/5/A 3rd Floor Sopanam Enclave Czech Colony Sanath Na, Gar, Hyderabad, Telangana, India – 500018
  • Industry
    Food And Beverages, Manufacturing, Artificial Fibres

To see the full contact details of Novalitha Pharma Private Limited, buy the company report.

Comprehensive company report
Novalitha Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Novalitha Pharma is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of Novalitha Pharma Private Limited, buy the company report.

Financials of Novalitha Pharma Private Limited

FY 2023 filings available

Novalitha Pharma Private Limited reported revenue of ₹84.41 Lakh (down 55% YoY) for FY 2023.

Revenue · FY 2023
₹84.41 Lakh ▼ 55%
Net loss · FY 2023
₹8.65 Lakh margin -10.2%
EBITDA · FY 2023
-₹5.68 Lakh margin -6.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 55%
3 years · compounded
▲ 17%
EBITDA CAGR growth
1 year
▼ 19%
3 years · compounded
▲ 19%

Revenue fell 55% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 17%. EBITDA fell 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹5.68 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹8.65 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin-6.7%
Net Profit Margin-10.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Novalitha Pharma Private Limited, buy the company report.

Board of directors of Novalitha Pharma Private Limited

Novalitha Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Surya Rao EasarlaManaging Director20 Sep 20188 Years 2 MonthsCurrent
Veera Venkata Ramana EasarlaDirector20 Sep 20188 Years 2 MonthsCurrent

Peer comparison

Novalitha Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Abhiraj Agencies Private Limited₹84.48 Lakh (FY 2019)305.0%Lucknow, Uttar Pradesh, India
Morzani India Private Limited₹84.46 Lakh (FY 2025)23.0%Jalpaiguri, West Bengal, India
Yogamaaya Arts Pvt Ltd₹84.45 Lakh (FY 2025)-31.0%Kolkata, West Bengal, India
Findindeed Private Limited₹84.45 Lakh (FY 2022)539.0%Delhi, India
Shamsheer Food & Chem Private Limited₹84.42 Lakh (FY 2025)41.0%Lucknow, Uttar Pradesh, India
Novalitha Pharma Private Limitedthis company₹84.41 Lakh (FY 2023)-₹8.65 Lakh-10.2%-55.0%Hyderabad, Telangana, India
Anita Distributors Private Limited₹84.37 Lakh (FY 2025)8.0%New Delhi, Delhi, India
Arjoi Retail Private Limited₹84.37 Lakh (FY 2025)32.0%New Delhi, Delhi, India
Ahrl Homoeo Private Limited₹84.34 Lakh (FY 2024)74.0%Kolkata, West Bengal, India
Pillsgo Healthcare Private Limited₹84.32 Lakh (FY 2025)-15.0%Aligarh, Uttar Pradesh, India
Rensel Tech Private Limited₹84.31 Lakh (FY 2025)-14.0%Chennai, Tamil Nadu, India

To see the full peer comparison of Novalitha Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹27 Lakh
Satisfied charges
None
Breakdown by lending institutions
Others₹0.27 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
02 Mar 2020100333517Others₹27 LakhOpen

Total charge records: 1 View all charges

Deals & funding

Novalitha Pharma Private Limited has 2 deals on record (1 funding round, 1 rights issue), with disclosed funding of ₹9 Lakh; the latest was in February 2021.

Total deals
2
Funding round
1
Rights issue
1
Disclosed funding
₹9 Lakh

Deals on record (2 of 2)

WhenDealAmountParties
Feb 2021Rights issue₹30 LakhInvestors: an individual
Mar 2019Funding round₹9 LakhInvestors: 2 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Novalitha Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Novalitha Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Novalitha Pharma Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Surya Rao Easarla ceased to be Director on 20 Sep 2021.

AGM
Novalitha Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Novalitha Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
Ceased
Surya Rao Easarla ceased to be Director.
Charges
A charge with Others amounted to Rs. 27.00 Lakh with Charge ID 100333517 was registered on 02 Mar 2020.
Appointed
Surya Rao Easarla was appointed as Managing Director.
Appointed
Veera Venkata Ramana Easarla was appointed as Director.
Incorporation
20 Sep 2018
Novalitha Pharma Private Limited was registered on 20 Sep 2018 with Roc Hyderabad & aged 8 years 2 months as per MCA records.

Frequently asked questions

Novalitha Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 20 September 2018 (8+ years old) and is registered under CIN U24303TG2018PTC126911.

Novalitha Pharma has 2 current directors:

The latest financial statements of Novalitha Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2019 are in the company report.

The CIN (Corporate Identification Number) of Novalitha Pharma is U24303TG2018PTC126911. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Novalitha Pharma was incorporated on 20 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.

Novalitha Pharma has 2 deals on record (1 funding round, 1 rights issue), with disclosed funding of ₹9 Lakh; the latest was in February 2021.

The peers of Novalitha Pharma by revenue are Abhiraj Agencies Private Limited, Morzani India Private Limited, Yogamaaya Arts Pvt Ltd, Findindeed Private Limited, Shamsheer Food & Chem Private Limited and 5 more, all in the same principal business activity (retail trading).

Surya Rao Easarla ceased to be Director on 20 Sep 2021. Surya Rao Easarla was appointed as Managing Director on 20 Sep 2018. Veera Venkata Ramana Easarla was appointed as Director on 20 Sep 2018.

The registered office of Novalitha Pharma is at F – 301 7 – 2 – 1735 And 18135A 3rd Floor Sopanam Enclave Czech Colony Sanath Na, Gar, Hyderabad, Telangana, India – 500018.

Novalitha Pharma operates in the food and beverages industry, in the manufacturing segment.

Novalitha Pharma has open charges of ₹27 Lakh and no satisfied charges on record as per latest MCA filings.